Teerakanok J, DeWitt JP, Juarez E, Thein KZ, Warraich I. Primary esophageal diffuse large B cell lymphoma presenting with tracheoesophageal fistula: A rare case and review. World J Gastrointest Oncol 2017; 9(10): 431-435 [PMID: 29085570 DOI: 10.4251/wjgo.v9.i10.431]
Corresponding Author of This Article
Irfan Warraich, MD, Department of Pathology, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States. irfan.warraich@ttuhsc.edu
Research Domain of This Article
Oncology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jirapat Teerakanok, Edna Juarez, Kyaw Zin Thein, Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, United States
Judy Park DeWitt, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX 79430, United States
Irfan Warraich, Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX 79430, United States
Author contributions: Teerakanok J and DeWitt JP contributed equally to this work and should be considered as co-first authors; Teerakanok J and DeWitt JP researched and reviewed literatures, wrote manuscript; Juarez E collected patient’s data; Thein KZ reviewed and wrote manuscript; Warraich I reviewed tissues pathology and conducted critical review.
Institutional review board statement: This case report does not require Texas Tech University Health Sciences Center IRB review.
Informed consent statement: Patient’s legal guardian provided verbal informed consent authorizing discloses and use his information.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Irfan Warraich, MD, Department of Pathology, Texas Tech University Health Sciences Center, 3601 4th Street, Lubbock, TX 79430, United States. irfan.warraich@ttuhsc.edu
Telephone: +1-806-7432155
Received: February 21, 2017 Peer-review started: February 23, 2017 First decision: May 7, 2017 Revised: May 30, 2017 Accepted: July 14, 2017 Article in press: July 17, 2017 Published online: October 15, 2017 Processing time: 233 Days and 21.4 Hours
Abstract
Primary non-Hodgkin lymphomas in the esophagus are rare. Tracheoesophageal fistulas mainly arise from solid esophageal carcinoma or mediastinal malignancies. Our patient presented with cough, dysphagia and weight loss, and upon initial computed tomography imaging and esophagogastroduodenoscopy, a malignant mass in the middle third of esophagus with tracheoesophageal fistula was found. The location of the mass and presence of malignant tracheoesophageal fistula were strongly suggestive of squamous cell carcinoma. However, tumor biopsy revealed diffuse large B-cell lymphoma. This case report details a rare incident of a primary diffuse large B-cell lymphoma presented as tracheoesophageal fistula and reviews previous literature.
Core tip: Primary non-Hodgkin lymphoma of esophagus is a rare disease, and tracheoesophageal fistula secondary to this condition prior to treatment is extremely rare and fatal. However, it has better prognosis than fistulas secondary to solid tumor if patients receive timely treatment.
